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ABSTRACT 
 
It has been proposed that epithelial cells can acquire invasive properties 
through exposure to paracrine signals originated from mesenchymal cells 
within the tumor microenvironment. Transforming Growth Factor-β (TGF-β) has 
been revealed as an active factor that mediates the epithelial-stroma cross talk 
that facilitates cell invasion and metastasis. TGF-β signaling is modulated by 
the co-receptor Endoglin (Eng), which shows a tumor suppressor activity in 
epithelial cells and regulates the ALK1-Smad1,5,8 as well as the ALK5-
Smad2,3 signaling pathways. In the current work we present evidence showing  
that cell surface Eng abundance in epithelial MCF-7 breast cancer cells is 
inversely related with cell motility. Shedding of Eng in MCF-7 cell surface by 
soluble MMP-14 derived from the HS-5 bone-marrow-derived cell line induces a 
motile epithelial phenotype. On the other hand, restoration of full-length Eng 
expression blocks the stromal stimulus on migration. Processing of surface Eng 
by stromal factors was demonstrated by Biotin-Neutravidin labeling of cell 
surface proteins and this processing generated a shift in TGF-β signaling 
through the activation of Smad2,3 pathway. Stromal MMP-14 abundance was 
stimulated by TGF-β secreted by MCF-7 cells acting in a paracrine manner. In 
turn, the stromal proteolytic activity of soluble MMP-14, by inducing Eng 
shedding, promoted malignant progression. From these data, and due to the 
capacity of TGF-β to regulate malignancy in epithelial cancer, we propose that 
stromal-dependent epithelial Eng shedding constitutes a putative mechanism 
that exerts an environmental control of cell malignancy.  
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INTRODUCTION 
 
There is strong evidence supporting the participation of stromal cells in 
carcinoma progression (1). Particularly, it has been demonstrated that cellular 
stromal components accomplish a crucial role in breast cancer growth and 
development (2). It is well known that stroma and epithelia maintain an active 
dialogue that produces functional reciprocal consequences. Thus, stromal 
soluble factors can modify the invasive potential of carcinoma cells and 
epithelial factors are responsible for the stromal desmoplastic response that 
characterizes some type of tumors (3). Carcinoma-associated fibroblasts 
(CAFs) have been identified as an established source of tumor and 
angiogenesis-promoting factors with a yet unraveled role in tumorigenesis (4). 
The origin of these CAFs is still a matter of debate, but there is no doubt that 
they exert an important influence in the invasive properties of carcinoma cells 
in either the primary or the metastatic niches (5). Homing and further 
proliferation of tumoral cells in the metastatic site is also strongly affected by 
the secondary stroma and its ability to provide signals that favor metastatic 
colonization as it occurs in breast metastasis to bone (6).  
 
Endoglin (CD105) is an integral membrane-bound glycoprotein, which acts as a 
transforming growth factor-β (TGF-β) auxiliary receptor (7). Endoglin (Eng) is 
highly expressed in endothelial cells and it has been proposed to play a key 
role during tumor neoangiogenesis (8). Besides the well-recognized pro-
angiogenic role of endothelial Eng, it has also been demonstrated that 
epithelial Eng is a crucial player in the carcinogenic phenomenon (9). Current 
evidence suggests that the main role of Eng in epithelial carcinogenesis is 
acting as a tumor suppressor molecule attenuating TGF-β1/Smad2/3 signaling 
(10). Conversely, knockdown of Eng in murine transformed keratinocytes 
stimulates basal and TGF-β-mediated ALK5/Smad2/3 signaling activity, a route 
that has been proposed to play a central role in the epithelial-mesenchymal 
transition (EMT) (10). 
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To date, data linking the development of metastatic disease with the 
expression of Eng are mostly limited to the role of Eng in tumor angiogenesis 
(11). However, an interesting and complementary research field has emerged 
with the identification in breast and colorectal cancer of elevated levels of a 
soluble form of Eng associated to a poor prognosis (12, 13). In search of the 
mechanisms by which Eng modulates cell motility, it has been demonstrated 
that overexpression of Eng in mouse fibroblasts lead to decreased migration in 
chemotactic and wound healing assays, as well as changes in the cellular 
morphology (14). 
 
The existence of a soluble form of Eng in plasma of breast cancer patients has 
been associated with the development of a metastatic disease (12). Also, in 
another study that evaluated serum Eng in patients with a variety of tumors, 
increased serum levels of Eng were associated with enhanced 
neovascularization of metastatic tumors (15). In these cases, it is possible to 
assume that the higher concentration of serum Eng was the consequence of a 
proteolytic processing of membrane-associated Eng, which seems to suggest 
that membrane shedding is a plausible possibility to control Eng abundance. In 
fact, using a colorectal carcinoma (CRC) model, it has been demonstrated that 
membrane-bound matrix metalloproteinase-14 (MMP-14; MT1-MMP) present in 
the surface of CRC cells cleaves Eng in close proximity to the transmembrane 
domain (16).  
 
Membrane-bound receptor shedding has been proposed as a functional 
mechanism to regulate growth factor signaling and usually it involves the 
proteolytic cleavage of the receptors’ extracellular domain (17). A similar 
phenomenon occurs with betaglycan, also a co-receptor for TGF-β, which after 
the proteolytic processing by MMP-14, generates a soluble form that competes 
with membrane-bound betaglycan for TGF-β binding, and in this manner, 
inhibits the cellular effect of the factor (18). 
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The aim of this study was to analyze mechanisms that mediate the stromal-
induced shedding of Eng in a human breast cancer cell line. We described for 
the first time that a stromal proteolytic activity, identified as a soluble form of 
MMP-14 present in the conditioned medium derived from a bone-marrow 
derived cell line (HS-5), cleaves membrane-bound Eng present in the weakly 
invasive MCF-7 cell line. We found that this paracrine Eng shedding gives rise 
to an increase in the migratory potential of the tumor cell that is reversed by 
the overexpression of membrane-bound Eng. In addition, we also studied the 
influence of TGF-β1, present in epithelial-derived soluble factors on stromal 
MMP-14 expression. These data suggests that stromal-derived MMP-14 is 
responsible for epithelial Eng shedding that, in turn, favors the expression of a 
more motile epithelial phenotype.   
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MATERIALS AND METHODS 
 
Cell culture, cell lines and chemicals. 
The human cell lines mammary breast MCF-7 and bone-marrow derived HS-5, 
obtained from the ATCC (Manassas, VA) were cultured in DMEM/F12 and DMEM 
medium (Invitrogen Carlsbad, CA), respectively, supplemented with 10% fetal 
bovine serum (FBS) (Hyclone, Logan UT) and maintained in a humidified 
atmosphere of 37°C, 5% CO2. Human Recombinant TGFβ1 and BMP-2 were 
purchased from R&D Systems (Minneapolis, MN). SB431542 inhibitor was from 
TOCRIS Bioscience (Business Park Ellisville, MO). GM6001 (Ilomastat) was 
purchased from Chemicon (Temecula, CA). Protein A Sepharose CL-4B was 
from Sigma (St. Louis MO). Sulfo-NHS-LC-Biotin and NeutraAvidin Sepharose 
were from Thermo (Waltham MA). Conditioned media (CM) were obtained by 
culturing confluent HS-5 and MCF-7 cells for 48h, in serum-free media (1 ml 
per 10 cm2 of culture area). CM was clarified by centrifugation and used 
freshly.  
 
Western blot and antibodies 
After treatments, cells were resuspended in lysis buffer (50 mM HEPES, pH 
7.4, 150 mM NaCl, 2 mM MgCl2, 2 mM EGTA, 1% Triton X-100 and 10% 
glycerol) supplemented with Complete protease inhibitors (Roche, Mannheim). 
Protein concentration of cell lysates was determined by a Bradford method 
(Fermentas, Maryland). Protein extracts were heat denatured in SDS–PAGE 
loading buffer 4X (240 mM Tris–HCl, pH 6.8, 8% SDS, 40% glycerol and 20% 
2-mercaptoethanol). Equal amounts of protein from different treatments were 
resolved by SDS-PAGE in 8% acrylamide gels and electrotransferred to 
polyvinylidene difluoride (PVDF) membranes using a buffer containing 24 mM 
Tris, 194 mM glycine and 20% methanol. Proteins were further analyzed using 
the ECL chemiluminescence detection kit (Amersham, Arlington Heights, FL). 
The immunoreactions were achieved by incubation of the membranes, 
previously blocked with a solution containing 5% BSA in Tris-buffered saline 
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(TBS) and 0.05% Tween 20 (Sigma, St. Louis, MO), with the following 
antibodies: rabbit anti human Eng (ab49228, Abcam, Cambridge, MA), rabbit 
anti phospho Smad2,3 (sc-11769), goat anti Smad2,3 (sc-6032), mouse anti 
Smad1 (sc-7965) and rabbit anti c-Myc (sc-789) were from Santa Cruz, (Santa 
Cruz, CA), rabbit anti p-Smad 1,5,8 (#9511, Cell Signaling, Danvers, MA), 
mouse anti EGF-R (19) mouse anti MMP-14 (MAB918, R&D Systems, 
Minneapolis, MN), mouse anti MMP-2 (Ab-3, Calbiochem, Cambridge MA), and 
mouse anti beta actin (A5441, Sigma Saint Louis, MO). Identifications of 
proteins in soluble fractions was performed as above in concentrated (10x) 
conditioned media using Vivaspin concentrators tubes (GE Healthcare, UK). 
Densitometric analysis of western blot bands was performed using Molecular 
Imaging Software, version 4.0 of Kodak (Rochester, NY). 
 
Cell migration assay 
MCF-7 cell migration was studied using a 6.5 mm Transwell chamber with a 
pore size of 8 µm (Corning, NY). The Transwell membranes were coated with 
10% fetal bovine serum in culture media for 2 h at 37ºC only on the lower 
chamber. Media conditioned by HS-5 cells (CM-HS-5) was prepared by 
incubating 5 x 104 cells per cm2 in a total volume of 8 ml of serum-free culture 
media for 48h. When required, MCF-7 cells were pretreated with a 50% (v/v in 
DMEM) solution of CM-HS-5 for 24h. Control and MC-HS-5-pretreated MCF-7 
cells (6x104) were re-suspended in serum-free medium and seeded on the 
upper compartment of the chamber. Migration was allowed to occur for 24h, 
after which cells of the upper membrane surface were removed by a cotton 
swab and repeatedly washed with PBS. For migration experiments in which 
MCF-7 Eng-overexpressing cells were used, control and CM-HS-5 pretreated 
cells were transiently transfected with a pSuper-C vector containing a wild-type 
version of the human Eng gene tagged with myc (20) using the TransIT 2020 
reagent (Mirus, Madison, USA) according to manufacturer’s instructions. A 
group of cells were pretreated with 10µM GM6001 (Ilomastat), a broad-range 
inhibitor of metalloproteinases (MMPs), prior to the migration assay, as 
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indicated. Migration values were determined by counting five fields (20X) per 
chamber after fixing and staining the migratory cells on the lower side of the 
membrane with 0.2% crystal violet in 10% methanol for 5 min (21).  
 
Reporter Assay 
Reporter assays using TGF-β-responsive promoters were performed as 
described previously (22), using p(CAGA)12-luc (23) and pId-lux (24) 
constructs, in the presence or the absence of TGF-β1, as indicated. All 
transient transfection experiments were carried out using TransIT 2020 
reagent (Mirus, Madison, USA) as vehicle for plasmids. Relative luciferase units 
were determined in a Berthold FB12 luminometer. The pRL-tk Renilla 
normalized luciferase vector (Promega, Madison WI) served as internal control 
to correct for transfection efficiency and for normalization.  
 
Biotinylation of Cell Surface Endoglin 
MCF-7 cells (108 per point) were incubated with increasing concentrations of 
MC-HS-5 for 48h. After treatment, cells were detached with EDTA (0.53 mM) 
and the cell suspension was washed two times with ice-cold phosphate-
buffered saline (PBS) pH 7.4 and each time centrifugated at 2,000 rpm at 4ºC. 
Sulfo-NHS-LC-Biotin (Thermo, Waltham MA) was dissolved in PBS pH 8.0 (final 
concentration 2mg/ml) and incubated with cell suspension for 5 hours at 4ºC 
with rotation. Unreacted biotinylating reagent was blocked two times for 15 
min with an equal volume of 10 mM of glycine in PBS. Cells pellet was lysed in 
a buffer containing 50 mM HEPES pH 7.4, 150 mM NaCl, 2 mM MgCl2, 2 mM 
EGTA, 1% Triton X-100 and 10% glycerol, supplemented with complete 
protease inhibitors (Roche, Mannheim), at 4°C. Next, the solution was 
sonicated twice for 5 sec and cleared by centrifugation at 13,000 for 10 min. 
Cleared supernatants were incubated overnight with 250 µL of NeutraAvidin 
Sepharose (Thermo, Waltham MA) at 4ºC. NeutraAvidin-bound proteins were 
separated by centrifugation at 2,500 rpm for 5 min and pellets were washed 4 
times with PBS. Then, pellets were resuspended with 100 µL of sample buffer 
4x (240 mM Tris-HCl, pH 6.8, 8% SDS, 40% glycerol and 20% 2-
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mercaptoethanol) boiled for 10 min and the supernatant was analyzed by SDS-
PAGE. 
 
MMP-14 immunoprecipitation 
To assess the role of stromal MMP-14 in the proteolytic capacity of CM-HS-5, 
MMP-14 was immunoprecipitated out from the HS-5 conditioned media. Briefly, 
8 µg of anti-human MMP-14 (MAB 918, R&D Systems, Minneapolis, MN) were 
incubated overnight with 200 µL of previously hydrated Protein A Sepharose 
CL-4B (Sigma, St. Louis). Then, 1.0 mL of a solution of 50% conditioned media 
(in DMEM) was subjected to a two rounds of immunoprecipitation with the 
matrix-bound antibody. The resulting supernatant was used to stimulate MCF-7 
migration as described above. 
 
Quantitative PCR 
Total RNA was isolated with Trizol (GIBCO) from CM MCF-7 and TGFβ1-treated 
HS-5 cells according to the manufacturer’s instructions. Reverse transcription 
to cDNA was performed using 1 µg of RNA from each sample using M-MLV 
reverse transcriptase and oligo (dTs) (Promega, Madison WI) as primer, 
according to the manufacturer’s protocol. MMP-14 mRNA expression was 
assessed by real time PCR using a Light Cycler instrument (Roche, Germany). 
The reaction was performed using 100 ng of cDNA and LightCycler® FastStart 
DNA Master SYBR Green I kit (Roche) in a final volume of 20 µL. All the 
reactions were performed in duplicate and negative controls were included. The 
primers used were: MMP14F (forward) 5’ CCTGCGTCCATCAACACT 3’, MMP14R 
(reverse) 5’ GCCCATGAATGACCCTCT 3’, GPDHF (forward) 5’ 
CAAAATCAAGTGGGGCGATGCTG 3’, GPDHR (reverse) 5’ 
TGTGGTCATGAGTCCTTCCACGAT 3’. The level of MMP-14 expression was 
normalized using GAPDH as loading control. 
 
Statistical analysis 
Experimental data are presented as mean ± standard deviation of experiments 
performed in triplicate. Data were subjected to a variance analysis, and 
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comparison among groups was performed by Kruskal-Wallis/Dunn’s multiple 
comparison test and Mann-Whitney unpaired t-test. In both cases the 
GraphPad Prism 5 software (GraphPad Software, San Diego, CA) was used. A 
value of p<0.05 was considered as a statistically significant difference. 
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RESULTS 
 
 
1. Media conditioned by HS-5 cell line stimulates the migratory capacity 
of MCF-7 cells by diminishing the abundance of Endoglin. 
Bone-marrow constitutes one of the main metastatic sites for breast cancer 
cells (25). Therefore, we hypothesized that soluble factors produced by a 
bone-marrow-derived cell line could modulate Eng expression and by this 
means, the migratory capacity of a breast cancer cell line. To evaluate this 
hypothesis, breast MCF-7 cells were pretreated with media conditioned by the 
bone-marrow-derived HS-5 stromal cell line (CM-HS-5) and their migratory 
capacity was measured using a transwell assay. In these experiments, CM-HS-
5 was not present during the migration assays. We also measured the 
expression of Eng in control and pretreated MCF-7 cells by western blot.  
Figure 1A shows that MCF-7 cells previously exposed to CM-HS-5 exhibit an 
enhanced migratory behavior. These cells also expressed a diminished amount 
of Eng. To verify that indeed the increase in migration was a consequence of a 
decrease in Eng expression, we subjected MCF-7 cells overexpressing a Myc-
tagged Eng to the stimulus of CM-HS-5. Figure 2B shows that the forced 
expression of Eng causes the reversion of the CM HS-5-dependent 
enhancement of migration, highlighting the role of Eng in epithelial migration. 
 
2. Pretreatment of MCF-7 cells with CM HS-5 enhanced Smad2/3 
and inhibits Smad 1, 5, 8 signaling. 
To investigate whether the decrease of Eng by CM HS-5 pretreatment has a 
consequence on TGF-β-dependent Smad signaling, we analyzed the 
phosphorylation pattern of Smad2,3 and Smad 1,5,8 in intact and pretreated 
cells. Figure 2A shows that CM HS-5 pre-treated MCF-7 cells displayed a 
diminished activation pattern of Smad1,5,8 that is more evident during the 
first 20 min of activation. By contrast, the same cells showed increased 
phosphorylation levels of Smad2,3, even at time zero, and maintained this 
activation for 30 min after stimulation. These results suggest that the 
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decreased amount of Eng in CM-HS-5 pretreated cells provoke a shift in TGF-β 
signaling enhancing the activation of the canonical Smad 2,3 pathway. To 
confirm the inhibition of ALK1/Smad1,5,8 pathway by CM-HS-5 pretreatment, 
we performed the same experiment using BMP2, the primary ligand of this 
route. As Figure 2B shows, pretreatment of MCF-7 cells with CM-HS-5 caused 
an evident inhibition of BMP2-induced phosphorylation of pSmad1,5,8.  
To assess whether this shift was consistent with the TGF-β-1-dependent 
transcriptional activity, intact and CM-HS-5 pretreated cells were used to 
activate pCAGA (23) and pId-lux (24) reporter constructs which are specific for 
Smad3 and Smad1,5,8 respectively. We found that both basal and TGF-β1-
stimulated pCAGA reporter activation was significantly stimulated in CM-HS-5 
pretreated cells (Figure 2C). On the other hand, pId-lux reporter responded 
poorly to TGF-β-1 stimulus in both experimental conditions (Figure 2D). 
However, when cells were stimulated with BMP-2, we observed a robust 
reporter activity which was significantly decreased in pretreated cells, 
supporting the view that the Smad 1,5,8 pathway is inhibited by CM-HS-5. 
 
3. Decreased MCF-7 Endoglin level after CM-HS-5 pre-treatment is 
partially due to a metalloproteinase-dependent shedding process. 
It has been demonstrated that a shedding process may occur during Eng 
posttranslational regulation (16). To test if a proteolytic processing mechanism 
is involved in the CM-HS-5-dependent reduction of Eng and the associated 
migratory enhancement, MCF-7 cells were pre-treated with CM-HS-5 in the 
presence or absence of 10 µM GM6001 (Ilomastat), a broad-range inhibitor of 
metalloproteinase (MMP) activity. Figure 3A shows that inhibition of MMP 
activity reduced the CM-HS-5-induced migratory enhancement of MCF-7 cells. 
These results suggest that decreased levels of membrane-bound Eng (mEng), 
responsible for the enhanced cell motility (Figure 1), could be caused, at least 
in part, by proteolysis.  
To confirm this hypothesis, MCF-7 cells were labeled at their surface with biotin 
(Biotin-NeutrAvidin procedure; see Material and Methods) and the Avidin-
bound Eng was identified by Western-blot analysis. Figure 3B shows that the 
Page 12 of 29Carcinogenesis
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
13 
 
abundance of cell surface Eng decreases, while soluble levels of Eng increase, 
in a dose-dependent manner after treatment with media conditioned by HS-5 
cell. These results suggest that the decrease of membrane Eng is due to a 
proteolytic processing that leads to an increase in the soluble levels of Eng 
(sol-Eng). 
 
4. TGF-β1 secreted by MCF-7 cells stimulates the production of MMP-
14 by HS-5 cells. 
The main hypothesis underlying our work is that stromal and epithelial 
compartments interchange soluble signals that modulate the course of tumoral 
progression. A previous work has shown that Eng shedding by a MMP-14 
activity was a phenomenon that resulted of the close proximity of both 
molecules (Eng and membrane bound MMP-14) in endothelial cell membrane 
(16). To assess if a similar process occurs in our system, the production of 
soluble and membrane-bound MMP-14 and MMP-2 (the most abundant stromal 
metalloproteinase) was measured in the epithelial and stromal cells used in our 
system. Figure 4A shows that HS-5 cells were the unique source of MMPs in 
their soluble and insoluble form, thus ruling out the possibility that Eng on 
MCF-7 cells was processed by endogenous MMPs of these cancer cells. 
Moreover, both soluble and insoluble forms of stromal MMP-14 show slightly 
increased levels when HS-5 cells were pre-incubated (16h) with medium 
conditioned by MCF-7 cells. No change was observed in the production of 
stromal MMP-2 upon treatment with MCF-7-derived soluble factors (Figure 4A, 
left panel). To test the mechanism involved in the production of stromal MMP-
14, HS-5 cells were treated for 48h with medium conditioned by MCF-7 (CM-
MCF-7) in the presence of increasing concentrations of SB431542, an inhibitor 
of the TGF-β type I receptor (TβRI) kinase. Figure 4B shows that CM-MCF-7 
enhances the abundance of soluble and membrane bound MMP-14 and this 
enhancement is abolished in a dose-dependent manner when TβRI kinase was 
added to the culture. This result strongly suggests the involvement of epithelial 
TGF-β1 on stromal MMP-14 production. This interpretation was further 
confirmed by the results presented in Figure 4C showing that the production of 
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the soluble form of MMP-14 is increased in a dose-dependent manner when 
HS-5 cells are cultured in the presence of TGF-β1. 
To assess if epithelial TGF-β1 exerts its activity on stromal MMP-14 production 
through a transcriptional mechanism, we replicated the experiments of Figures 
4B and 4C and measured the MMP-14 mRNA expression by qPCR. Figure 4D 
shows that the expression of MMP-14 mRNA in HS-5 cells treated with CM-
MCF-7 or TGF-β1 followed a similar response as the MMP-14 protein, 
suggesting a transcriptional regulation of MMP-14 under these conditions. 
 
5. Depletion of MMP-14 from the medium conditioned by HS-5 cells 
reverts its pro-migratory effect on MCF-7 cells.  
To address whether MMP-14 present in CM-HS-5 was directly involved in the 
acquisition of motile properties by MCF-7 cells, we performed a subset of 
migration experiments in which MMP-14 present in conditioned media was 
previously depleted by a serial immunoprecipitation procedure. Figure 5A 
shows that pre-treatment of MCF-7 cells with increasing concentrations of CM-
HS-5 gave rise to a dose-dependent enhancement of their migratory capacity. 
When the most concentrated solution (50% CM-HS-5) was subjected to 
immunoprecipitation using an anti MMP-14 antibody, the stromal-induced 
migratory capacity decreased in direct proportion with the decline of residual 
MMP abundance in CM-HS-5, as demonstrated by Western blot analysis (Figure 
5B). These results allow us to propose that MMP-14 present in the medium 
conditioned by HS-5 cells is responsible for shedding of epithelial membrane 
Eng and, in consequence, of the increased MCF-7 cells migration observed 
after preincubation of MCF-7 cells with CM-HS-5.  
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DISCUSSION 
 
Interactions with stromal fibroblasts at the primary site of tumors create a 
favorable microenvironment supporting cancer growth, survival, evasion of 
immune surveillance and resistance to therapy (2). Results in the present work 
support the hypothesis that a stromal soluble form of the MMP-14 enzyme, 
acting in a paracrine manner, can modulate the migratory behavior of MCF-7 
breast cancer cells by proteolytically processing the membrane-bound Eng 
present in these epithelial cells. 
 
The production of proinvasive proteinases (as MMPs) is a common feature in 
numerous carcinomas, including breast, stomach, lung, colon and head-and-
neck tumors (26). MMP-14 belongs to a subtype of MMP predominantly located 
at membrane level and it is not only produced by the carcinoma associated 
fibroblasts, but it is also detected at the malignant epithelial level (27, 28). 
This evidence prompted us to suggest that stromal MMP-14 can be cleaved at 
the cell surface to be further taken up by carcinoma cells (29). Membrane-
bound MMP-14 undergoes a complex process of shedding producing a series of 
soluble active and inactive fragments. Among them, the 50-53 kDa fragments 
correspond to the entire ectodomain of the enzyme and are active species. 
Moreover, the 44 kDa fragment is derived from a self-regulatory mechanism 
that reduces pericellular proteolytic activity and corresponds to an inactive 
form (30). 
 
Increased levels of serum MMP-14 have been identified in breast cancer 
patients without clinically apparent metastases suggesting that this MMP is 
produced through a shedding process attributable to an enhancement of 
proteolytic environment that characterizes tumor progression (31). In line with 
these data, our results show that a soluble form of MMP-14, generated by HS-5 
bone marrow-derived cells, sheds the membrane-bound Eng on MCF-7 surface 
by a mechanism that includes an epithelial stimulus mediated by TGF-β1. The 
inductive role of bone-marrow stromal cells on the acquisition of the malignant 
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properties of breast cancer cells has been evaluated in a variety of 
experimental models (32). Thus, the paracrine modulation of endoglin 
expression in tumor cells by CM-HS-5, demonstrated here, may contribute to 
the growth and malignant transformation of tumors. In this regard, silencing of 
epithelial Eng has been proposed as a relevant mechanism to control cell 
migration and invasion in vitro (10). In a human mammary cells model, it has 
been hypothesized that Eng expression attenuates pro-migratory and pro-
invasive effects of TGF-β1 in cells containing active oncogenes; in this case the 
expression level of Eng does not affect TGF-β1 signaling (33). It has also been 
demonstrated that shedding of surface-bound Eng constitutes a plausible 
regulatory mechanism of angiogenesis (16). These authors showed evidence 
that a surface-located MMP-14 was able to cleave Eng in endothelial cells, a 
phenomenon that may regulate the angiogenic potential in a tumor 
microenvironment.  
 
Our experiments were performed using a weakly invasive tumor carcinoma 
cells (MCF-7) that express Eng at low levels and does not express detectable 
amounts of MMPs either at the pericellular and soluble levels. Conversely, the 
stromal cellular component, represented here by the HS-5 cell line, is an active 
producer of MMPs, a common fact in many human peritumoral fibroblasts (28). 
From our data we propose that stromal HS-5 cells produce and secrete a 
soluble form of MMP-14 that sheds epithelial Eng through a proteolytic process 
triggered by TGF-β1 secreted by the same breast epithelial cells (Figure 6). 
Thereby, overexpression of epithelial TGF-β1, acting in a paracrine manner, 
could serve as a signal to produce a stromal proteolytic activity (MMP-14) that, 
in turn, stimulates the shedding of epithelial Eng, reinforcing the establishment 
of a malignant state. This potential mechanism is obviously restricted to 
weakly invasive carcinoma cells, which express detectable levels of Eng, and 
might represent an early step in the onset of tumor progression. In fact, in a 
study that evaluated by in situ-RT-PCR the expression of MMPs in breast tumor 
samples, MMP-14 appears to have the highest levels of gene expression in the 
pre-invasive tumours examined, suggesting a role for MMP-14 in the tumor 
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invasion process (34). Similarly, in pancreatic ductal adenocarcinoma (PDAC), 
a deadly human malignancy characterized by its desmoplastic nature, an 
increased expression of MMP-14 is correlated with an up-regulation of TGF-β1, 
a factor that promotes MMP-14 expression (35). 
 
In mechanistic terms, we propose that changes in migratory behaviour 
resulting from Eng shedding may be associated with changes in TGF-β 
signalling. Previous work has proposed that, as result of the extracellular and 
cytoplasmic interactions of Eng with ALK5 and ALK1, the latter route is 
potentiated (9). Our data shows that, after preincubation of MCF-7 with CM-
HS-5, the expression of surface bound Eng declines and consequently, the 
Smad1,5,8 pathway is inhibited, whereas Smad2/3 phosphorylation is 
stimulated. In many cellular systems it has been demonstrated that TGF-β1-
induced activation of Smad3 constitutes a critical step for cellular events that 
play a key role in the induction of cell migration (36, 37). 
 
Taken together, this study reinforces the idea that the fate of a malignant 
epithelial cell depends largely on its interaction with an active stroma (2). In 
this case we propose (Figure 6) that the endogenous autocrine production of 
TGF-β, a characteristic trait of epithelial malignancy, may act in a paracrine 
manner, stimulating the production of a soluble form of stromal MMP-14 that, 
in turn, cleaves the membrane-bound epithelial Eng. It has been clearly 
demonstrated that disruption of membrane Eng is an important event in tumor 
progression. Therefore, it is highly possible that Eng-processed cells acquire a 
whole set of malignant traits (autocrine TGF-β production, among others) that 
perpetuates the expression of a more motile malignant phenotype. 
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Medium conditioned by HS-5 cell line stimulates the migratory capacity of MCF-7 by diminishing the 
abundance of Endoglin.  
A. MCF-7 cells were pretreated (24h) with media conditioned by the stromal cell line (CM-HS-5) and further 
assayed for their migratory capacity using the Transwell method in the absence of CM-HS-5. Inset shows 
the expression of Eng protein in treated and non-treated cells determined by Western blot. B. MCF-7 cells 
that overexpress a Myc-tagged full-length version of Eng (ENG+) were subjected to migration as in A. As a 
control, cells transfected with an empty vector (EV) were included. Inset shows expression of Eng protein. 
Bars indicate the average of migrating cells per field. (**) indicates significant differences with p<0.01.  
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Pretreatment of MCF-7 cells with CM HS-5 enhances Smad 2,3 and inhibits Smad 1,5,8 signaling.  
A. Western blot analysis of the Smad1,5,8 and Smad2,3 phosphorylation relative to the total expression 
levels, in controls and CM-HS-5-pretreated MCF-7 cells at different times of treatment with TGF-β1 
(5ng/ml). Values at the bottom of each lane indicate the relative densitometry of phospho-Smad respect to 
total Smad. B. Western blot analysis of the Smad1,5,8 phosphorylation relative to the total expression 
levels, at different times of treatment with 25 ng/ml of BMP2 in control and CM-HS-5-pretreated MCF-7 
cells. C-D. TGF-β1 and BMP2-induced transcriptional activation of pCAGA (C) and Id1 (D) luciferase reporter 
genes. Control and CM-HS-5-treated MCF-7 cells were transiently transfected with the reporter contructs 
and treated or not with TGF-β1 or BMP2, as indicated. Figures are representatives of three separate 
experiments. (***) indicates significant differences with p<0.01.  
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Decreased Endoglin levels in MCF-7 cells after CM-HS-5 pre-incubated is partially due to a 
metalloproteinase-dependent shedding process.  
A. Migration rate of MCF-7 cells pre-treated or not with CM-HS-5 in the presence or absence of GM 6001 
(Ilomastat), as indicated. B. Western blot of soluble (sol-Eng) and cell-surface bound Eng (mEng) after 
treatment with increasing concentrations of CM-HS-5. Cell surface bound Eng was labeled using a Biotin-
NeutrAvidin method. EGF receptor was used as loading control of the biotinylated membrane fraction. 
Figures are representatives of three independent experiments. (***) indicates significant differences with 
p<0.01.  
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TGF-β1 secreted by MCF-7 cells stimulates the production of MMP-14 by HS-5 cells.  
A. Stromal HS-5 and epithelial MCF-7 cells were pretreated or not with 50% CM-MCF-7 or CM-HS-5, 
respectively, for a 16h period. Afterwards, cells were washed and incubated for 24h in serum-free medium. 
Then, culture supernatants were collected and cellular monolayers were lysed. MMP-14 and MMP-2 
abundance was analyzed by Western blot in the soluble fraction and in the lysate. B. HS-5 cells were 
incubated with media conditioned by MCF-7 cells (50%) for 48h in the presence or absence of SB431542, 
inhibitor of TβRI kinase, and the MMP-14 protein abundance was analyzed both in the soluble fraction and 
cell lysate by Western blot. C. HS-5 cells were incubated for 16h in the presence of increasing 
concentrations of TGF-β1 and MMP-14 protein was analyzed by Western blot. D. HS-5 cells were incubated 
in the same experimental conditions than in B and C. At the end of the incubation period, cells were lysed 
with Tryzol and mRNA levels of MMP-14 were measured by qPCR.  
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Depletion of MMP-14 from media conditioned by HS-5 cells reverts its pro-migratory effect on MCF-7 cells.  
MCF-7 cells were subjected to migration after pretreatment for 24 h with increasing concentrations of CM-
HS-5 as in Figure 1. A portion of the more concentrated conditioned media (50%) was subjected to a serial 
immunoprecipitation procedure using an anti MMP-14 antibody bound to Protein A Sepharose. A. Migration 
rate of MCF-7 cells pre-treated with intact CM-HS-5 and with media depleted of MMP-14 for one or two 
cycles (IP1 and IP2) of immunoprecipitation. B. Western blot of residual MMP-14 activity in CM-HS-5 after 
two cycles of immunoprecipitation.  
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Hypothetical model for epithelial-stromal cross-talk that modulates endoglin-dependent epithelial migration. 
The capacity of tumor cells to provide the initial stimulus of TGF-β could be responsible for the production of 
a soluble form of stromal MMP-14 which, by shedding the epithelial membrane-bound Eng, stimulates 
ALK5/Smad2,3 signaling pathway resulting in the enhancement of cell motility.  
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